
|Videos|March 21, 2016
Achieving Value in Specialty Pharmacy
Author(s)Davy James, Managing Editor
National Association of Specialty Pharmacy (NASP) Executive Director James E. Smeeding, RPh, MBA, discusses the cost burden of long term care compared with the high cost of short term treatment with specialty drugs.
Advertisement
National Association of Specialty Pharmacy (NASP) Executive Director James E. Smeeding, RPh, MBA, discusses the cost burden of long term care compared with the high cost of short term treatment with specialty drugs.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Tarlatamab-Dlle to Treat Adults With Extensive Stage Small Cell Lung Cancer
2
Newly Approved Specialty Drugs Advance Care for Inflammatory and Autoimmune Diseases
3
FDA Approves Sevabertinib for HER2-Mutant Non-Small Cell Lung Cancer
4
New Enlicitide Decanoate Data Show Significant LDL-C Reductions in At-Risk Patients
5














































































































































































































